Role of the angiopoietin-like protein family in the progression of NAFLD.
Angiopoietin-like protein
Hepatocellular carcinoma
Metabolic syndrome
NAFLD
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
received:
09
01
2024
revised:
05
03
2024
accepted:
06
03
2024
medline:
1
4
2024
pubmed:
1
4
2024
entrez:
1
4
2024
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease, with a range of conditions including non-alcoholic fatty liver, non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Currently recognized as the liver component of the metabolic syndrome, NAFLD is intimately linked to metabolic diseases. Angiopoietin-like proteins (ANGPTLs) comprise a class of proteins that resemble angiopoietins structurally. It is closely related to obesity, insulin resistance and lipid metabolism, and may be the critical factor of metabolic syndrome. In recent years, many studies have found that there is a certain correlation between ANGPTLs and the occurrence and progression of NAFLD disease spectrum. This article reviews the possible mechanisms and roles of ANGPTL protein in the pathogenesis and progression of NAFLD.
Identifiants
pubmed: 38560164
doi: 10.1016/j.heliyon.2024.e27739
pii: S2405-8440(24)03770-8
pmc: PMC10980950
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e27739Informations de copyright
© 2024 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.